Medtronic Accused Of Off-Label Marketing Kickbacks Scheme

Law360, New York (May 11, 2012, 6:35 PM EDT) -- A whistleblower lawsuit unsealed in Mississippi federal court Friday alleges Medtronic Inc. and affiliated doctors violated the False Claims Act through a kickback scheme promoting off-label use of Medtronic's Infuse bone graft product and Pyramid spine plate system.

The suit, unsealed after federal prosecutors declined to intervene, alleges Medtronic's claims to federal health programs like Medicare and Medicaid were fraudulent because the company falsely said it didn't violate the federal Anti-Kickback Statute. According to the complaint, Medtronic secretly paid doctors to promote its products to patients...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America v. Medtronic, Inc. et al


Case Number

3:11-cv-00413

Court

Mississippi Southern

Nature of Suit

Other Statutory Actions

Judge

Carlton W. Reeves

Date Filed

July 8, 2011

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.